---
layout: page
exclude: true
---
## Cis-platin and analogs

| Name | Structure |
| :---: | :---: |
| cis-platin | ![cis-platin](https://upload.wikimedia.org/wikipedia/commons/thumb/8/80/Cisplatin-stereo.svg/1024px-Cisplatin-stereo.svg.png){:width="30%"} |
| carboplatin | ![carboplatin](https://upload.wikimedia.org/wikipedia/commons/thumb/4/42/Carboplatin-skeletal.svg/800px-Carboplatin-skeletal.svg.png){:width="30%"} |
| oxaliplatin | ![Oxaliplatin](https://upload.wikimedia.org/wikipedia/commons/7/76/Oxaliplatin-2D-skeletal.png){:width="30%"} |

### Mechanism of action

* Cisplatin crosslinks DNA by binding adjacent [guanine](https://en.wikipedia.org/wiki/Guanine) bases on a strand.
* Cisplatin affects the cell by changing the conformation of the DNA, and thus, changing how it interacts with proteins.

### Interactions with target
Normal DNA: PDB ID [3dnb](https://www.rcsb.org/structure/3dnb)

Cis-platin bound DNA: PDB ID [3lpv](https://www.rcsb.org/structure/3lpv)

Proteins of the _high mobility group DNA-binding_ family (HMG-domain proteins) prefer to bind to bent DNA, and thus bind to bent cisplatin-bound DNA, as seen in PDB ID [1ckt](https://www.rcsb.org/structure/1ckt). The HMG protein then shields the cisplatin-damaged DNA from other proteins involved in DNA replication, repair, and transcription.

These events collectively trigger [apoptosis](apoptosis.md) or programmed cell death.

### Resistance
Tumors can develop resistance to cisplatin treatment by several ways, including changing the traffic of cisplatin across the cell membrane and down-regulating mechanisms that cause cell death. [Oxaliplatin](https://en.wikipedia.org/wiki/Oxaliplatin) is used when resistance develops.


---

[MDCM790 Home page](mdcm790.md)
